PT-141 (10mg Vial)
PT-141 (bremelanotide) is an agonist of melanocortin receptors (MC3R/MC4R), with central activity in the hypothalamus—an area linked to sexual desire and appetite regulation.
It activates sexual arousal circuits in the central nervous system, differing from approaches focused only on vasodilation/perfusion.
Key Benefits
Erectile dysfunction (ED): effective in men who do not respond well to PDE5 inhibitors (e.g., Viagra/Cialis).
Improves sexual desire in both men and women.
Provides a significant increase in libido and physical response within a short period after administration.
PT-141 (bremelanotide) is an agonist of melanocortin receptors (MC3R/MC4R), with central activity in the hypothalamus—an area linked to sexual desire and appetite regulation.
It activates sexual arousal circuits in the central nervous system, differing from approaches focused only on vasodilation/perfusion.
Key Benefits
Erectile dysfunction (ED): effective in men who do not respond well to PDE5 inhibitors (e.g., Viagra/Cialis).
Improves sexual desire in both men and women.
Provides a significant increase in libido and physical response within a short period after administration.
Technical Details
Part Number
Item Weight
Product Dimensions
Item model number
Item Package Quantity
Number of Handles
Batteries Required?
product without indications
FDA approval (2019): based on Phase III studies showing a significant improvement in desire and reduced sex-related distress in women.
Safarinejad study (2008): a randomised clinical trial assessing PT-141 in men who did not respond to sildenafil (Viagra), reporting positive outcomes.
product without recommended dosages
